Crossmark

Rechallenge with immune checkpoint inhibitors therapy for patients with HCC-lot more to learn

Crossref DOI link: https://doi.org/10.1007/s12072-024-10751-w

Published Online: 2024-11-20

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lau, George https://orcid.org/0000-0002-8928-3769
License Information

Text and Data Mining valid from 2024-11-20

Version of Record valid from 2024-11-20
More Information

Article History

Received: 16 October 2024

Accepted: 4 November 2024

First Online: 20 November 2024

Free to read: This content has been made available to all.